Patents by Inventor Mazin Magzoub

Mazin Magzoub has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of oligopyridylamides to inhibit mutant p53 amyloid formation and restore its tumor suppressor function
    Patent number: 10500197
    Abstract: The invention relates to oligopyridylamide alpha-helix mimetic compounds and their use to inhibit p53 aggregation and restore its tumor suppressor function for treating diseases, e.g., cancers, associated with p53 mutations, e.g., R248W p53 mutation.
    Type: Grant
    Filed: July 18, 2018
    Date of Patent: December 10, 2019
    Assignees: New York University, New York University in Abu Dhabi Corporation
    Inventors: Sunil Kumar, Andrew D. Hamilton, Mazin Magzoub, Sarah Hassan
  • USE OF OLIGOPYRIDYLAMIDES TO INHIBIT MUTANT P53 AMYLOID FORMATION AND RESTORE ITS TUMOR SUPPRESSOR FUNCTION
    Publication number: 20190022075
    Abstract: The invention relates to oligopyridylamide alpha-helix mimetic compounds and their use to inhibit p53 aggregation and restore its tumor suppressor function for treating diseases, e.g., cancers, associated with p53 mutations, e.g., R248W p53 mutation.
    Type: Application
    Filed: July 18, 2018
    Publication date: January 24, 2019
    Applicant: New York University
    Inventors: Sunil KUMAR, Andrew D. Hamilton, Mazin Magzoub